← All stocks

Corcept Therapeutics Inc

CORTPharmaceuticalsLatest filing used: 2026-11-03Filings on SEC EDGAR ↗

Above fair value Strong balance sheet Fast grower High cash margin Flags raised Uncertain estimate

Fair value per share

$39.35

from SEC filings only

Last close

$72.95

Nov 13, 2026

85.4% above fair value

Margin of safety price
$29.51
25% below fair value
Stress case
$11.05
if things go badly

Its filings point to about $39.35 a share, most likely between $22.02 and $58.04.

Where it sits

340 of the 653 stocks we value that have a close are even further above their estimates.

Counts the 653 stocks that have both a value and a close as of Nov 13. Positions are squeezed so the biggest gaps fit.

The short case

In favour

  • It turns about 33% of its sales into cash in a typical year.
  • Sales have grown about 17% a year over the last five years.
  • It holds more cash than debt.

Against

  • Its last close is about 85% above what its filings say it is worth.
  • Cash margins have fallen well below the typical year this value uses, so it may overstate the business today.
  • Revenue has grown faster than the model's 15% a year limit, which may understate value.

Written automatically from the filings, by the same rules for every company. Not a recommendation.

Price tags

The last close next to our fair value, the filings-based estimate above. Profit and cash flow: the 12 months to September 30, 2026.

MeasureAt last close$72.95Nov 13At our fair value$39.35
Market valueAll 123 million shares at that price (the diluted count, which includes stock options and awards)$9.0B$4.8B
Price / earnings (P/E)Dollars paid for each $1 of yearly profit56.4×30.4×
Price / free cash flowDollars paid for each $1 of cash left each year after paying for equipment46.2×24.9×
EV / EBITDAPrice of the whole business (shares plus debt, less cash) for each $1 of yearly profit before interest, tax and wear and tearNot shown: we couldn't find every number this needs in the filings.Not shown: we couldn't find every number this needs in the filings.

Our own arithmetic on the filings, the last close and our fair value, which is an estimate. One unusual year can push any of these very high or very low. How we work these out

Five areas

16 of 25 checks passedStrong in 3 of 5 areas

GrowthStrong · 4 of 5
  • Revenue up 5%+ a year over 3 years (passed)
  • Revenue up 5%+ a year over 5 years (passed)
  • Earnings per share up 5%+ a year over 5 years (not passed)
  • Revenue up over the last 12 months (passed)
  • Earnings per share up over the last 12 months (passed)
ProfitabilityFair · 3 of 5
  • Return on equity of 15%+ (last 12 months) (passed)
  • Return on equity of 12%+ (5-year average) (passed)
  • Return on invested capital of 10%+ (5-year average) (no data)
  • Operating margin of 10%+ (5-year average) (passed)
  • Operating margin holding up (last 12 months vs 5 years) (not passed)
Cash generationStrong · 4 of 5
  • Cash earnings positive in almost every year (at most one bad year) (passed)
  • Typical year turns 10%+ of revenue into cash (passed)
  • Latest year at or above the typical year (not passed)
  • Free cash flow positive (last 12 months) (passed)
  • Revenue larger than 5 years ago (passed)
Balance sheetStrong · 4 of 5
  • Debt no larger than equity (no data)
  • Cash and short-term investments exceed debt (passed)
  • Positive shareholders' equity (passed)
  • Debt clearly tagged in the filings (passed)
  • Operating margin above zero (last 12 months) (passed)
Shareholder returnsWeak · 1 of 5
  • Pays a dividend (not passed)
  • Dividend paid in each of the last 5 years (not passed)
  • Dividend grew over 5 years (no data)
  • Pays out 75% or less of earnings (no data)
  • Share count flat or falling over 5 years (passed)

Flags

Cash margins have fallen well below the typical year this value uses, so it may overstate the business today.

Revenue has grown faster than the model's 15% a year limit, which may understate value.

Some working-capital lines are only partly tagged, so yearly cash earnings are noisier.

How we got this number

In a typical year CORT kept 25% of its revenue as cash after running and maintaining the business (before interest). We assume revenue grows 12.8% a year for five years, then slows to 2.5% by year ten, and discount the cash at 10.2% a year (the 10-year Treasury yield plus 5 points). That is worth $39.35 a share today.

Technical details
Model
Discounted cash flow on cash earnings
Cash-earnings margin: typical year (worst / best 3-year stretch)
25.3% (11.8% / 36.9%)
Years used
2018–2025
Revenue growth, years 1–5 (range tested)
12.8% (8 to 18%)
Capital needed per $1 of new revenue
$0.00 equipment, $-0.03 working capital
Discount rate
10.2%
Revenue base
$0.8B (lower of TTM and last FY)
Debt / cash
$0.0B / $0.4B
Value if investors require Treasury + 3 / + 8 points (we use + 5)
$49.79 / $29.84
If growth after year 10 keeps today's returns
$44.95
Likely range
10th–90th percentile of 4,000 runs with different assumptions
Required return
10-year Treasury 5.15% (2026-11-13) + 5%

What the price assumes

For our model to reach the last close of $72.95 (Nov 13, 2026), CORT would have to keep 49¢ of every $1 of sales as cash. Its best year was 39¢ and a typical year 25¢.

What the price needs
49¢
Its typical year
25¢
Its last 3 years
12¢
Its best year
39¢

So the price is betting on more than we assume: a higher margin than in any of the 8 years we checked, faster or longer growth than our rules allow, a discount rate below our 10.2%, or something our model leaves out. Our growth rules are cautious: growth is capped at 15% a year and adds no value after year 10.

Typical, best and worst years are from the 8 years we checked in its filings (2018–2025). Everything else stays as described above, including the growth path and the discount rate.

Technical details

Value per share is a straight line in the margin until it reaches zero: value = margin × cash factor − (growth spending + debt and other claims) per share. We solve for the margin that gives the last close, with growth, discount rate, equipment and working capital held as in the main model.

Revenue base $761M. Growth 12.8% for five years, fading to 2.5% by year 10. Discount rate 10.2%. At 25.3¢ the filings-based value is $39.35. Each extra 1¢ of margin adds $1.41 a share. The last close is $72.95, which is $33.61 above the filings-based value, so the margin would have to rise by 23.8¢, to 49.1¢.

Terminal rule: Growth after year 10 earns only the discount rate, so it adds no value.

Ten years of results

Revenue

$761M in FY2025, up 13% on the year before

FY2016: $81MFY2017: $159MFY2018: $251MFY2019: $306MFY2020: $354MFY2021: $366MFY2022: $402MFY2023: $482MFY2024: $675MFY2025: $761M$400M$800MFY16FY19FY22FY25$761M
Show as table
YearRevenue
FY2016$81M
FY2017$159M
FY2018$251M
FY2019$306M
FY2020$354M
FY2021$366M
FY2022$402M
FY2023$482M
FY2024$675M
FY2025$761M

Cash earnings as a share of sales

5.5% of sales in FY2025

FY2018: 38.6%FY2019: 36.1%FY2020: 35.8%FY2021: 32.7%FY2022: 17.9%FY2023: 13.1%FY2024: 16.7%FY2025: 5.5%0%20%40%FY16FY19FY22FY255%
Show as table
YearCash earnings as a share of sales
FY2016–
FY2017–
FY201838.6%
FY201936.1%
FY202035.8%
FY202132.7%
FY202217.9%
FY202313.1%
FY202416.7%
FY20255.5%

Shares outstanding

Share count rose 3% over 9 years

FY2016: 116MFY2017: 125MFY2018: 127MFY2019: 123MFY2020: 124MFY2021: 126MFY2022: 116MFY2023: 112MFY2024: 113MFY2025: 120M075M150MFY16FY19FY22FY25120M
Show as table
YearShares outstanding
FY2016116M
FY2017125M
FY2018127M
FY2019123M
FY2020124M
FY2021126M
FY2022116M
FY2023112M
FY2024113M
FY2025120M

No dividends paid in these years.

Delayed quote

Delayed price and chart from TradingView. This site does not receive or store these prices, and the fair value above does not use them. Showing the chart sends TradingView this page's address, the widget type, the ticker and your IP address, and TradingView may collect analytics; see Privacy.

Open on Yahoo Finance ↗

Sources. Company figures: SEC EDGAR (XBRL filings), latest filing used 2026-11-03. Interest rate: U.S. Treasury, 10-year par yield, 2026-11-13. Last close: IEX Historical Data, 2026-11-13. Price tags: our own arithmetic on the SEC figures, the last close and our fair value.